- Enova funds NOK 10 million for a 20MW electrolyser at Rafnes.
- The project aims to reduce CO2 emissions by 22,000 tonnes.
- INEOS plans a 30% emission reduction by 2030.
- The electrolyser will produce hydrogen and oxygen using green electricity.
Project Overview
INEOS, through its subsidiary INOVYN, plans to establish one of Norway's first hydrogen plants based on water electrolysis at Rafnes in Vestfold and Telemark. The pre-project has received NOK 10 million in funding from Enova.
Green Hydrogen Production
INOVYN, a significant player in the Norwegian petrochemical sector, will build a 20MW electrolyser at the Rafnes site. This electrolyser will produce pure hydrogen and oxygen using green electricity, aiming to reduce CO2 emissions by 22,000 tonnes and lower the carbon footprint of INEOS businesses in Norway.
Emission Reduction Goals
The Aquarius project is a crucial step towards INEOS' goal of achieving zero emissions by 2050. The project is part of a broader decarbonisation roadmap targeting a minimum 30% reduction in emissions by 2030 compared to 2020 levels. Enova's support is vital for addressing technical risks and advancing the project.
Technological Innovation
The project involves integrating the water electrolyser with the core petrochemical process without interference. This requires innovation, testing, and the development of new models and systems for advanced process control. The goal is to make green hydrogen production competitive by reducing both investment and operating costs.
Future Plans
Initially, Enova supports the pre-project with NOK 10 million. INOVYN is preparing a main project to purchase an electrolyser for hydrogen and oxygen production. Additionally, INOVYN will explore the potential of producing hydrogen for the transport sector.
European Initiative
INEOS plans to invest over €2 billion in electrolysis projects to produce zero-carbon, green hydrogen across Europe. The first plants will be built in Norway (Project Aquarius), Germany, and Belgium, with further investments planned in the UK and France.
